A Comparative Analysis of Arterial Blood Flow in Unexplained Infertility, Tubal Infertility and Fertile Groups
NCT ID: NCT02393235
Last Updated: 2015-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
217 participants
OBSERVATIONAL
2015-03-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Baseline and First Trimester Uterine Artery Doppler Velocimetry to Predict Poor Obstetric Outcomes in IVF
NCT05661539
The Effect of Embryo Transfer Technique on Pregnancy Outcomes in HRT-FET Cycles
NCT05564312
The Effect of Baseline Bilateral Uterine Artery Doppler Velocimetry on Obstetric Outcomes in HRT-FET Cycles
NCT05526014
Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles
NCT03887728
The Accuracy of Endometrial Ultrasound to Predict Implantation
NCT03860636
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
unexplained infertility(n:75)
Ovarian, uterine and spiral artery pulsatility index and resistance index will measure with doppler ultrasonography in the mid-luteal phase. ( 21th day)
doppler ultrasonography
Ovarian, uterine and spiral artery pulsatility index and resistance index will measure
tubal infertility(n:75)
Ovarian, uterine and spiral artery pulsatility index and resistance index will measure with doppler ultrasonography in the mid-luteal phase. ( 21th day)
doppler ultrasonography
Ovarian, uterine and spiral artery pulsatility index and resistance index will measure
fertile group(n:75)
Ovarian, uterine and spiral artery pulsatility index and resistance index will measure with doppler ultrasonography in the mid-luteal phase. ( 21th day)
doppler ultrasonography
Ovarian, uterine and spiral artery pulsatility index and resistance index will measure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
doppler ultrasonography
Ovarian, uterine and spiral artery pulsatility index and resistance index will measure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal prolactin levels
* normal thyroid stimulation hormone levels
* no ovarian or pelvic surgery history
Exclusion Criteria
* receive medical treatments which may influence the clearance or excretion of gonadotropins and sex steroids
22 Years
37 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bagcilar Training and Research Hospital
OTHER_GOV
Suleymaniye Birth And Women's Health Education And Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ali G Zebitay, M.D.
Role: PRINCIPAL_INVESTIGATOR
Suleymaniye Birth And Women's Health Education And Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suleymaniye Birth And Women's Health Education And Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGZ1-UN-DOP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.